KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Income from Continuing Operations (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Income from Continuing Operations data on record, last reported at 276290000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 29.26% year-over-year to 276290000.0; the TTM value through Dec 2025 reached 142163000.0, down 662.11%, while the annual FY2025 figure was 142163000.0, 662.11% down from the prior year.
  • Income from Continuing Operations reached 276290000.0 in Q4 2025 per CRL's latest filing, down from 55556000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 189106000.0 in Q4 2022 and bottomed at 276290000.0 in Q4 2025.
  • Average Income from Continuing Operations over 5 years is 62747150.0, with a median of 92088500.0 recorded in 2021.
  • Peak YoY movement for Income from Continuing Operations: surged 48.94% in 2022, then plummeted 213.12% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 139827000.0 in 2021, then surged by 35.24% to 189106000.0 in 2022, then decreased by 0.08% to 188952000.0 in 2023, then tumbled by 213.12% to 213747000.0 in 2024, then decreased by 29.26% to 276290000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 276290000.0 in Q4 2025, 55556000.0 in Q3 2025, and 52693000.0 in Q2 2025.